Accelerate to discover

Back to filter

Related topics

IncuCyte webinar: Latest developments in live-cell analysis & advanced cell models

Sartorius

Sep 26, 2018

Biomedical researchers are increasingly using advanced human cell models for translational biology and therapeutic...

Quantitative characterization of metaphase cellular events using 3D imaging cellular events 

Yokogawa

Sep 20, 2018

In conventional monolayer cell culture systems, cell nuclei show dynamic and cyclic changes in theirshape and height....

IncuCyte webinar: Live-cell analysis of cell subsets and heterogeneity

Sartorius

Sep 3, 2018

Discover the new IncuCyte S3 cell-by-cell analysis software module. The innovative module allow label free analysis to...

ACEA Biosciences introduces an exploratory xCELLigence RTCA S16 instrument

Acea Biosciences

Aug 30, 2018

The company has just introduced the xCELLigence RTCA S16, which is the ideal entry level model for exploratory studies...

Oct 16, 2018

X-RAD 160 qube

Precision X-Ray

Aug 23, 2018

The new X-RAD 160 qube is suitable for either mounting on the lab bench or mobile on an optional wheeled cart, allowing...

Low shear micro-gravity, a better way to do 3D cell culture

Synthecon

Aug 20, 2018

A variety of technologies for cell and tissue culture have been developed since the first use of glass or plastic...

Webinar Tuning Microenvironment to Control Cells for Improved Disease Modeling & Immunotherapy Work

Xcell Biosciences

Jul 16, 2018

The company producing Avatar, xCELL biosciences have organized a webinar about the tuning of microenvironment to...

Oct 16, 2018

Real-time verification of clonality using IncuCyte system

Sartorius

Jun 28, 2018

Use whole-well, label-free imaging to automatically scan for clones and verify monoclonality. Integrated image...

Show all topics (10)

The evaluation of three digital PCR platforms for residual disease in chronic myeloid leukemia

Oct 11, 2016

Thursday, October 13, 2016, 5 pm CEST

Mary Alikian, Ph.D., Imperial Molecular Pathology laboratory and the Department of Haematology at Hammersmith Hospital, Imperial College London

The BCR-ABL1 fusion gene sequence is used to help diagnose and monitor treatment and recurrence for chronic myelogenous leukemia (CML). In fact, between 90-95% of diagnosed CML cases are BCR-ABL1-positive. While reverse transcription quantitative PCR (RT-qPCR) is the gold standard strategy for monitoring BCR-ABL1 transcripts, there can often be challenges with reproducibility due to the technology and workflow. Reverse-Transcription Digital PCR (RT-dPCR) is an adaptation of this method that could provide the robust and standardized workflow needed for patient stratification. In this webinar, Dr. Mary Alikian at Hammersmith Hospital, Imperial College London, discussed her team’s comparison of three different available dPCR platforms (ThermoFisher Scientific’s QuantStudio 3D System, Bio-Rad’s QX200 System and RainDance’s RainDrop System) and investigation of whether they could be applied to a clinical research setting to quantify BCR-ABL1 transcripts in CML patients. The team determined that only the RainDrop System was able to detect and quantitatively measure BCR-ABL1 transcripts in the <0.001% range at a level higher than the false positive rate in the control patient groups.

Register now

Technical breakthrough
Webinar

Related technologies: Digital PCR

Get more info

Regina Fillerová

Field application specialist

Regina

Fillerová

+420 731 127 718

Send Message

Brand profile

RainDance Technologies

RainDance company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases.

Related products

Capable of generating more than a billion reactions in a single day, the RainDrop system surpasses all existing technologies and establishes a new performance standard in sensitivity, quantitation and multiplexing.

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey